Team Financial Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3
Closed -$99 – 43
2023
Q4
$99 Hold
3
– – ﹤0.01% 211
2023
Q3
$85 Buy
+3
New +$98 ﹤0.01% 198

Other funds holding ARKG

Team Financial Group's ARKG Position: Q1 2024 in Review

Team Financial Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 3 shares — an estimated $99 sold.

Team Financial Group first reported a position in ARKG in Q3 2023 and held it in 2 quarters. The position peaked at $99 in Q4 2023. 286 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Team Financial Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Team Financial Group sold 3 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $99.
  • Team Financial Group first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 2 quarters.
  • Team Financial Group's ARK Genomic Revolution ETF position peaked at $99 in Q4 2023.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Team Financial Group's 13F filing for Q1 2024, filed 13 May 2024.